Skip to content

LAPRESS study

The effectiveness of laparoscopic niche resection versus expectant management in patients with secondary subfertility and a large uterine caesarean scar defect (niche) on reproductive outcomes, a randomised controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28650
Enrollment
200
Registered
2017-02-20
Start date
2017-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Laparoscopic niche resection, contraceptives during the first 6 months to enable healing of the uterine scar before a pregnancy is allowed, thereafter fertility therapies are allowed if needed, accord

Sponsors

VU medical center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women (>18 years) with the presence of a large niche and secondary unexplained subfertility, failed IVF, or with problems during their fertility therapy, such as intrauterine accumulation of fluid and/ or difficulties during the introduction of the ET of IU catheter will be included.

Exclusion criteria

Exclusion criteria: Pregnancy, age < 18 years, contraindications for general anaesthesia, a (suspected) malignancy, uterine of cervical polyps, submucosal fibroids, atypical endometrial cells, cervical dysplasia, cervical or pelvic infection, hydrosalphinx.

Design outcomes

Primary

MeasureTime frame
Time to ongoing pregnancy, defined as a intrauterine pregnancy with a fetal heartrate at 12 weeks gestation.

Secondary

MeasureTime frame
Fertility and pregnancy outcomes, satisfaction and quality of life, surgical outcomes (intervention group), additional interventions, niche characteristics. Economic evaluation: direct and indirect costs will be executed from a social perspective.

Contacts

Public ContactJ.A.F. Huirne
j.huirne@vumc.nl,020-4444444

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)